期刊文献+

糖皮质激素受体表达与特发性血小板减少性紫癜激素抵抗关系 被引量:3

Relationship between glucocorticoid receptors and glucocorticoid resistance in children with idiopathic thrombocytopenia purpura
原文传递
导出
摘要 目的通过研究原发性糖皮质激素抵抗型特发性血小板减少性紫癜(ITP)患儿糖皮质激素受体(GR)亚型GRα和GRβ表达水平,以揭示ITP糖皮质激素抵抗的可能机制。方法应用实时荧光定量-PCR法检测18例糖皮质激素敏感型、12例糖皮质激素抵抗型ITP患儿及10例正常儿童外周血单个核细胞GRα和GRβmRNA的表达水平,同时采用酶免疫分析法测定血清总皮质醇水平。结果①对照组、糖皮质激素敏感组和抵抗组3组之间GRαmRNA的表达水平差异无显著性;对照组和糖皮质激素敏感组的GRβmRNA水平差异无显著性,但糖皮质激素抵抗组的GRβmRNA水平显著高于对照组和糖皮质激素敏感组,差异有显著性(P<0.01)。②总皮质醇水平在对照组与糖皮质激素敏感组之间差异无显著性,但糖皮质激素抵抗组总皮质醇水平明显高于糖皮质激素敏感组,差异有显著性(P<0.01)。结论ITP患儿糖皮质激素抵抗可能与GRβmRNA的表达增高有关。 Objective To identify the relationship between the expression of α and β-isoforms of glucocorticoid receptors (GR) in peripheral blood mononuclear cells (PBMC) and glucocortieoid resistance in children with idiopathic thrombocytopenia purpura (ITP). Methods Real-time PCR was used to detect the expression of GRα and GRβ mRNA in PBMC from 30 children with ITP (glucoeorticoid-sensitive, n = 18; glucocorticoid-resistant, n = 12) and 10 healthy children ( control group). Enzyme immunoassay was used to measure plasma levels of total glucocoticoits. Results There were no significant differences in PBMC GRα mRNA levels among the glucoeorticoid-sensitive, the glucocorticoid-resistant and the control groups. Compared with the glucocorticoid-sensitive and the control groups, the expression of GRβ mRNA in the glucocorticoid-resistant group was significantly up-regulated (P〈0.01). Plasma total glucocoticoits level in the glucocorticoid-resistant group was found to be much higher than that in the glueocorticoid-sensitive and the control groups (P 〈 0.01 ). Conclusions The up-regulated expression of GRβ mRNA may associated with glucocorticoid resistance in children with ITP.
机构地区 深圳市儿童医院
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2009年第9期714-716,共3页 Chinese Journal of Contemporary Pediatrics
关键词 特发性血小板减少性紫癜 糖皮质激素受体 激素抵抗 儿童 Idiopathic thrombocytopenia purpura Glucoeorticoid receptor Glucocorticoid resistance Child
  • 相关文献

参考文献6

二级参考文献13

  • 1HuZhang,QinOuyang,Zhong-HuiWen,ClaudioFiocchi,Wei-PingLiu,Dai-YunChen,Feng-YuanLi.Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitis[J].World Journal of Gastroenterology,2005,11(12):1775-1778. 被引量:4
  • 2陈灏珠.实用内科学(第10版)[M].北京:人民卫生出版社,1998.1765-1767.
  • 3田英 徐仁宝.人外周血白细胞皮质激素受体的测定[J].中华核医学杂志,1983,1(3):27-27.
  • 4张之南.血液病学[M].北京:人民卫生出版社,2003.1101-1106.
  • 5Yudt MR,Jewell CM, Bienstock RJ, et al. Molecular origins for the dominant negative function of human glucocorticoid receptor beta [J]. Mol Cell Biol,2003,23(12) :4319-4330.
  • 6Falus A, Biro J, Rakasz E. Cytokine networks and corticosteroid receptors [ J ]. Ann N Y Acad Sci, 1995,762 : 71-77.
  • 7Adcock IM, Ford PA, Bhavsar P, et al. Steroid resistance in asthma:mechanisms and treatment options [ J ]. Curr Allergy Asthma Rep,2008,8(2) :171-178.
  • 8Panitsas FP, Theodoropoulou M, Kouraklis A, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response [ J ]. Blood, 2004, 103 ( 7 ) : 2645 -2647.
  • 9Wang J, van Dongen H, Scherer HU, et al. Suppressor activity among CD4^ + ,CD25^+ T cells is discriminated by membrane-bound tumor necrosis factor alpha [ J ]. Arthritis Rheum, 2008,58 ( 6 ) : 1609-1618.
  • 10Leung DY, Hamid Q, Vottero A,et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta[ J ]. J Exp Med , 1997,186(9 ) : 1567-1574.

共引文献16

同被引文献36

  • 1何小解,易著文,党西强,张慧琼,何庆南,莫双红,白海涛,耿文茂,杨华彬.GRβ在原发性肾病综合征患儿糖皮质激素耐药中的作用[J].中华儿科杂志,2005,43(2):109-112. 被引量:22
  • 2吴小川,易著文,何小解,党西强,赵维玲.小儿紫癜性肾炎肾脏病理定量分析[J].湖南医科大学学报,2000,5(4):403-405. 被引量:52
  • 3黄文彦,徐虹,周利军,曹琦,郭怡清.儿童激素耐药性肾病综合征临床、病理及预后分析[J].临床儿科杂志,2005,23(4):217-219. 被引量:11
  • 4Kobayashi T, Kimura H, Okada Y, et al. Increased CDllb expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease[J]. Clin Exp Immunol,2007,148(1):112-118.
  • 5Miura M, Kohno K, Ohki H, et al. Effects of methyl- prednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin [J]. EurJ Pediatr, 2008,167(10) :1119-1123.
  • 6Ayusawa M, Sonobe T, Uemura S, et al. Revision of di- agnostic guidelines for Kawasaki disease (the 5th revised edition)[J]. Pediatr Int, 2005,47(2) : 232-234.
  • 7Wikstrom AC. Glucocorticoid action and novel mecha- nisms of steroid resistance: role of glucocorticoid recep- tor-interacting proteins for glucocorticoid responsiveness [J]. J Endocrinol, 2003 , 178(3) : 331-337.
  • 8Liakopoulos OJ, Schmitto JD, Kazmaier S, et al. Car- diopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery[J]. Ann Thorac Surg,2007,84(l) :110-118.
  • 9Makata H, Ichiyama T, Uchi R, etal. An'ti-inflammato- ry effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease[J]. Naunyn Schmiedebergs Arch Pharmacol, 2006 ,373(5) :325-332.
  • 10Ichiyama T, Ueno Y, Isumi H, etal. An immunoglob- ulin agent (IVIG) inhibits NF-kappa B activation in cul- tured endothelial ceils of coronary arteries in vitro[J]. Infiamm Res,2004 ,53(6) :253-256.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部